OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Thymosin alpha1 use in adult COVID-19 patients: A systematic review and meta-analysis on clinical outcomes
Weifeng Shang, Bo Zhang, Yali Ren, et al.
International Immunopharmacology (2022) Vol. 114, pp. 109584-109584
Open Access | Times Cited: 8
Weifeng Shang, Bo Zhang, Yali Ren, et al.
International Immunopharmacology (2022) Vol. 114, pp. 109584-109584
Open Access | Times Cited: 8
Showing 8 citing articles:
Sepsis: the evolution of molecular pathogenesis concepts and clinical management
Zhongxue Feng, Lijun Wang, Jing Yang, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Zhongxue Feng, Lijun Wang, Jing Yang, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
A pilot trial of Thymalfasin (Ta1) to prevent covid-19 infection and morbidities in renal dialysis patients: Preliminary report
Cynthia Tuthill, Ahmed Awad, M Parrigon, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109950-109950
Open Access | Times Cited: 5
Cynthia Tuthill, Ahmed Awad, M Parrigon, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109950-109950
Open Access | Times Cited: 5
Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model
Daniela Ricci, Marilena P. Etna, Martina Severa, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109996-109996
Open Access | Times Cited: 5
Daniela Ricci, Marilena P. Etna, Martina Severa, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109996-109996
Open Access | Times Cited: 5
Phenotypic drug discovery: a case for thymosin alpha-1
Enrico Garaci, Maurizio Paci, Claudia Matteucci, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Enrico Garaci, Maurizio Paci, Claudia Matteucci, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Review of Thymic Peptides and Hormones: From Their Properties to Clinical Application
Monika Besman, Aleksandra Zambrowicz, Magdalena Matwiejczyk
International Journal of Peptide Research and Therapeutics (2024) Vol. 31, Iss. 1
Open Access
Monika Besman, Aleksandra Zambrowicz, Magdalena Matwiejczyk
International Journal of Peptide Research and Therapeutics (2024) Vol. 31, Iss. 1
Open Access
Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanisms
Zirui Wang, Cong Wang, X Fei, et al.
Pneumonia (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Zirui Wang, Cong Wang, X Fei, et al.
Pneumonia (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Early use of Thymalfasin prevents progression of common COVID-19 infection to severe pneumonia
Zirui Wang, Cong Wang, X Fei, et al.
Research Square (Research Square) (2023)
Open Access
Zirui Wang, Cong Wang, X Fei, et al.
Research Square (Research Square) (2023)
Open Access
AN UMBRELLA REVIEW ON TREATMENTS AND THERAPEUTIC OPTIONS FOR COVID-19
SeyedAhmad SeyedAlinaghi, Amir Masoud Afsahi, Ayoob Molla, et al.
Russian Journal of Infection and Immunity (2023) Vol. 13, Iss. 5, pp. 885-898
Open Access
SeyedAhmad SeyedAlinaghi, Amir Masoud Afsahi, Ayoob Molla, et al.
Russian Journal of Infection and Immunity (2023) Vol. 13, Iss. 5, pp. 885-898
Open Access
